Quote | Super Quote
Date   Code Name No. of Shares Issued Issue Price Total Fund Raised Type % of issued shs Raising Method
(Reason)
17/04/2025 02367GIANT BIOGENE35.000MHKD 66.650HKD 2.333BShares3.379Top Up Placing
(Enlarging the capital base;Business Development)
17/04/2025 03896KINGSOFT CLOUD18.000MHKD 5.830HKD 104.940MShares0.473Placing/Issue
(Enlarging the capital base;Business Development Net proceeds equivalent to USD12.99 mil)
17/04/2025 03896KINGSOFT CLOUD259.500MUSD 0.751USD 194.971MShares6.819Placing/Issue
(Enlarging the capital base;Business Development Offer price equal to USD 11.27 per ADS; Each unit of ADS is equivalent to 15 shs)
17/04/2025 03896KINGSOFT CLOUD69.375MHKD 5.830HKD 404.456MShares1.823Placing/Issue
(Enlarging the capital base;Business Development Net proceeds equivalent to USD 52.14 mil)
16/04/2025 00343CULTURECOM HOLD200.000MHKD 0.031HKD 6.200MWarrants11.986Placing/Issue
(Enlarging the capital base)
16/04/2025 00653BONJOUR HOLD1.343BHKD 0.080HKD 107.450MShares300.000Rights Issue/Open Offer
(Enlarging the capital base;Business Development Rts 3 for 1 (on non-underwritten basis); Net proceeds of HK$56.39 mil will be set off against the shareholder's loans)
16/04/2025 08246ZHONGHUA GAS230.000MHKD 0.119HKD 27.370MShares5.702Consideration Issue
(Debt Repayment Loan capitalization)
16/04/2025 00769CHINA RAREEARTH48.750MHKD 0.320HKD 15.600MShares2.082Placing/Issue
(Enlarging the capital base)
16/04/2025 02425AUSTASIA GROUP280.185MHKD 1.120HKD 313.810MShares40.000Rights Issue/Open Offer
(Enlarging the capital base;Debt Repayment Rts 2 for 5 (on non-underwritten basis))
15/04/2025 00136CHINA RUYI----HKD 2.341BConvertible Bonds0.000Placing/Issue
(Enlarging the capital base;Business Development)
15/04/2025 00970NEW SPARKLEROLL93.800MHKD 0.402HKD 37.700MShares20.000Placing/Issue
(Enlarging the capital base)
14/04/2025 00464CHINA IN-TECH46.000MHKD 0.220HKD 10.100MShares7.755Placing/Issue
(Enlarging the capital base;Debt Repayment)
14/04/2025 00660WAI CHUN BIOTEC----HKD 15.000MConvertible Bonds0.000Consideration Issue
(Debt Repayment)
11/04/2025 01091SOUTH MANGANESE685.692MHKD 0.210HKD 144.000MShares20.000Placing/Issue
(Enlarging the capital base;Debt Repayment)
11/04/2025 02309ZO FUTURE GROUP37.634MHKD 1.860HKD 70.000MShares4.616Placing/Issue
(Enlarging the capital base;Debt Repayment)
11/04/2025 08196FUTIAN HOLDINGS6.000MHKD 0.260HKD 1.560MShares18.787Placing/Issue
(Enlarging the capital base)
11/04/2025 00995ANHUIEXPRESSWAY49.982MHKD 10.450HKD 522.311MH3.013Placing/Issue
(Enlarging the capital base;Business Development)
11/04/2025 03395JX ENERGY----USD 1.515MConvertible Bonds0.000Consideration Issue
(Debt Repayment Principal amount equivalent to approx. HKD 11.79 mil)
11/04/2025 01013WAI CHUN GROUP----HKD 45.000MConvertible Bonds0.000Consideration Issue
(Debt Repayment)
11/04/2025 02340ISP HOLDINGS212.425MHKD 0.051HKD 10.830MShares50.000Rights Issue/Open Offer
(Enlarging the capital base Rts 1 for 2 (on non-underwritten basis))
11/04/2025 02309ZO FUTURE GROUP69.892MHKD 1.860HKD 130.000MShares8.573Placing/Issue
(Enlarging the capital base;Debt Repayment)
10/04/2025 01783ENVISION GREEN4.545MHKD 7.700HKD 35.000MShares0.334Consideration Issue
(Acquisition Acquisition of business in waste management & handling in Singapore)
09/04/2025 00290GOFINTECH QUANT372.924MHKD 1.120HKD 417.670MShares5.000Placing/Issue
(Enlarging the capital base;Business Development)
09/04/2025 01693BGMC7.200MHKD 1.200HKD 8.640MShares20.000Placing/Issue
(Enlarging the capital base)
08/04/2025 08189TEDA BIOMEDICAL103.500MHKD 0.375HKD 38.813MH5.098Placing/Issue
(Enlarging the capital base;Business Development)
08/04/2025 00340TONGGUAN GOLD327.420MHKD 0.690HKD 225.920MShares8.044Placing/Issue
(Enlarging the capital base;Business Development)
08/04/2025 01643MODERN CHI MED120.000MHKD 0.270HKD 32.400MShares20.000Placing/Issue
(Enlarging the capital base;Business Development)
07/04/2025 00575REGENT PACIFIC63.377MHKD 0.485HKD 30.738MShares27.744Consideration Issue
(Debt Repayment Loan capitalization; Consideration equivalent to approx USD 3.96 mil.)
03/04/2025 00484FORGAME25.000MHKD 0.610HKD 15.250MShares17.039Placing/Issue
(Enlarging the capital base;Business Development)
03/04/2025 00778FORTUNE REIT5.453MHKD 4.131HKD 22.526MShares0.268Consideration Issue
(Fee Payment)
03/04/2025 02191SF REIT4.463MHKD 2.864HKD 12.782MShares0.547Consideration Issue
(Fee Payment)
02/04/2025 02616CSTONE PHARMA-B80.000MHKD 2.933HKD 234.640MShares6.229Placing/Issue
(Enlarging the capital base;Business Development)
02/04/2025 00764ETERNITY INV----HKD 9.000MConvertible Bonds0.000Placing/Issue
(Enlarging the capital base)
01/04/2025 01520VIRTUAL MIND124.764MHKD 0.400HKD 49.900MShares18.606Placing/Issue
(Enlarging the capital base;Business Development;Debt Repayment)
01/04/2025 01991TA YANG GROUP120.000MHKD 0.100HKD 12.000MShares9.136Placing/Issue
(Enlarging the capital base;Business Development)
01/04/2025 08223ZYY----HKD 10.000MConvertible Bonds0.000Placing/Issue
(Enlarging the capital base;Business Development;Debt Repayment)
01/04/2025 01983LUZHOU BANK1.000B----H36.795Placing/Issue
(Enlarging the capital base)
01/04/2025 00405YUEXIU REIT50.348MHKD 0.850HKD 42.796MShares0.989Consideration Issue
(Fee Payment Consideration equal to RMB 39.5 mil)
31/03/2025 00493GOME RETAIL284.117MHKD 1.255HKD 356.567MShares0.593Consideration Issue
(Debt Repayment Consideration equal to USD 45.89 mil)
30/03/2025 00939CCB11.327BRMB 9.270RMB 105.000BA4.531Placing/Issue
(Enlarging the capital base)
 
 1    2    3    4    5    6    7    8    9    10  
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.